China SXT Pharmaceuticals Inc (SXTC) — Free Cash Flow Generation Index
China SXT Pharmaceuticals Inc (SXTC) has a Free Cash Flow Generation Index of 0.89x as of December 2022. Free cash flow of $208.90K represents 1% of operating cash flow ($234.18K). Explore China SXT Pharmaceuticals Inc (SXTC) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China SXT Pharmaceuticals Inc Free Cash Flow Generation Index (2016–2020)
Historical FCF Generation Index trend for China SXT Pharmaceuticals Inc across 5 annual periods. For the full cash flow conversion analysis, see China SXT Pharmaceuticals Inc (SXTC) cash conversion ratio.
Annual Free Cash Flow Generation for China SXT Pharmaceuticals Inc (2016–2020)
Year-by-year Free Cash Flow Generation Index for China SXT Pharmaceuticals Inc. Check China SXT Pharmaceuticals Inc (SXTC) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.56x | $527.59K | $934.25K | $406.66K | ▲ +136.4% |
| 2019 | -1.55x | $-370.89K | $239.19K | $610.09K | ▼ -442.5% |
| 2018 | 0.45x | $869.44K | $1.92 Million | $1.05 Million | ▲ +24.3% |
| 2017 | 0.36x | $106.73K | $293.04K | $186.31K | ▼ -22.3% |
| 2016 | 0.47x | $85.48K | $182.47K | $96.99K | — |